Tirofiban Hydrochloride

FDA Drug Profile — Tirofiban Hydrochloride

Drug Details

Generic Name
Tirofiban Hydrochloride
Brand Names
Tirofiban Hydrochloride
Application Number
ANDA213947
Sponsor
Farmabios S.p.A.
NDC Codes
6
Dosage Forms
POWDER, INJECTION, INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
TIROFIBAN HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Tirofiban hydrochloride injection is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). Tirofiban hydrochloride injection is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). ( 1 )